We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$84.7B
AUM Growth
+$3.15B
Cap. Flow
-$3.2B
Cap. Flow %
-3.77%
Top 10 Hldgs %
10.93%
Holding
2,264
New
35
Increased
617
Reduced
853
Closed
525

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$128M
2
DHR icon
Danaher
DHR
+$114M
3
ZBRA icon
Zebra Technologies
ZBRA
+$112M
4
AIZ icon
Assurant
AIZ
+$92.7M
5
EXC icon
Exelon
EXC
+$92.2M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.17%
3 Financials 13.51%
4 Industrials 10.72%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLE icon
1351
Allegion
ALLE
$13.3B
$1.04M ﹤0.01%
9,901
CSGS
1352
DELISTED
CSG Systems International
CSGS
$1.04M ﹤0.01%
18,200
PAR icon
1353
PAR Technology
PAR
$676M
$1.03M ﹤0.01%
39,587
-12,310
-24% -$317K
WIX icon
1354
WIX.com
WIX
$2.35B
$1.03M ﹤0.01%
13,367
-8,678
-39% -$701K
WGO icon
1355
Winnebago Industries
WGO
$877M
$1.02M ﹤0.01%
19,400
-337
-2% -$19.2K
FUTU icon
1356
Futu Holdings
FUTU
$14.5B
$1.02M ﹤0.01%
25,146
-7,558
-23% -$369K
SVC
1357
Service Properties Trust
SVC
$1.09B
$1.02M ﹤0.01%
27,870
-211
-0.8% -$7.74K
EBF icon
1358
Ennis
EBF
$550M
$1.01M ﹤0.01%
45,800
BLFS icon
1359
BioLife Solutions
BLFS
$1.46B
$1.01M ﹤0.01%
55,673
-18,728
-25% -$387K
FINM
1360
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
$1.01M ﹤0.01%
100,000
FSK icon
1361
FS KKR Capital
FSK
$3.04B
$1.01M ﹤0.01%
57,747
VRAY
1362
DELISTED
ViewRay, Inc.
VRAY
$1.01M ﹤0.01%
225,678
-70,175
-24% -$305K
CUBI icon
1363
Customers Bancorp
CUBI
$2.65B
$1.01M ﹤0.01%
35,600
-23,209
-39% -$723K
GO icon
1364
Grocery Outlet
GO
$930M
$1M ﹤0.01%
34,242
-10,292
-23% -$323K
FG icon
1365
F&G Annuities & Life
FG
$3.93B
$998K ﹤0.01%
+49,884
New +$1.02M
OI icon
1366
O-I Glass
OI
$1.43B
$991K ﹤0.01%
59,800
-4,389
-7% -$70.7K
LII icon
1367
Lennox International
LII
$19B
$987K ﹤0.01%
4,127
+247
+6% +$60.5K
GES
1368
DELISTED
Guess Inc
GES
$983K ﹤0.01%
47,500
-2,926
-6% -$53.8K
GKOS icon
1369
Glaukos
GKOS
$8.8B
$981K ﹤0.01%
22,465
+22,054
+5,366% +$1.09M
OSH
1370
DELISTED
Oak Street Health, Inc.
OSH
$980K ﹤0.01%
45,544
-165,482
-78% -$3.46M
UCTT
1371
Ultra Clean Holdings
UCTT
$3.73B
$965K ﹤0.01%
29,100
-9,300
-24% -$297K
ARCH
1372
DELISTED
Arch Resources, Inc.
ARCH
$957K ﹤0.01%
6,700
-3,600
-35% -$527K
IP icon
1373
International Paper
IP
$22.2B
$951K ﹤0.01%
27,463
+13,469
+96% +$466K
ANSS
1374
DELISTED
Ansys
ANSS
$949K ﹤0.01%
3,928
+1,507
+62% +$351K
BIO icon
1375
Bio-Rad Laboratories Class A
BIO
$8.48B
$947K ﹤0.01%
2,252

Similar funds

Macquarie Group's Q4 2022 Portfolio in Review

As of Q4 2022, Macquarie Group held 2,264 positions worth $84.7B, up 3.9% from $81.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $3.2B in Q4 2022, closing 525 positions and reducing 853 holdings. Its most notable exit was Abiomed Inc, an estimated $124M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in iShares 0-5 Year Investment Grade Corporate Bond ETF worth $58.3M.

  • Macquarie Group's largest Q4 2022 buy was iShares 0-5 Year Investment Grade Corporate Bond ETF: 1,218,670 shares worth $58.3M.
  • Macquarie Group added most to L3Harris in Q4 2022, an estimated $128M increase.
  • Macquarie Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $189M.
  • Macquarie Group fully exited Abiomed Inc in Q4 2022, selling an estimated $124M.
  • Macquarie Group's ten largest holdings make up 11% of its $84.7B portfolio in Q4 2022.
  • Macquarie Group opened 35 new positions and closed 525 in Q4 2022.
  • Macquarie Group's portfolio value rose 3.9% quarter-over-quarter to $84.7B.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.